Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Database
Main subject
Language
Document Type
Year range
1.
J Bus Res ; 157: 113550, 2023 Mar.
Article in English | MEDLINE | ID: covidwho-2165496

ABSTRACT

Consumer animosity captures negative attitudes to foreign products and impacts willingness to buy them. Existing constructs nevertheless fail to account for an emerging dimension: pandemic animosity. This article heeds recent calls to develop a pandemic animosity measurement scale. Its purpose is to: (i) extend Klein et al.'s (1998) animosity model by adding the pandemic animosity construct, (ii) provide a measurement scale for pandemic animosity, and (iii) explain how pandemic animosity impacts consumers' willingness to buy. Study 1 analyzes qualitative data from in-depth personal interviews with NVivo to identify themes and codes. An expert panel helped reach consensus of all indicators. Study 2 filters scale items using a pilot sample. Study 3 validates a 12-item scale with a larger representative sample. The results contribute to the consumer animosity literature by confirming the existence of pandemic animosity, providing an actionable measure, and confirming its negative impact on consumers' willingness to buy.

2.
Infect Disord Drug Targets ; 2022 Apr 06.
Article in English | MEDLINE | ID: covidwho-2114948

ABSTRACT

Since the advent of the COVID-19 pandemic in 2019, a mammoth research activity targeting the etiological features of COVID-19 has commenced. Many aspects of the disease have been studied, and various others are under consideration. The secondary microbial co-infections with COVID-19 have generated some serious concerns across the globe. This review mainly focuses on the notable secondary co-infections. The co-infection of influenza, tuberculosis, and typhoid may mimic the original COVID-19 symptoms. Physicians and clinicians must focus on the secondary co-infections which may aggravate the disease progression towards acute respiratory disorder syndrome (ARDS). Diagnostic strategies must also be redefined to determine the actual underlying secondary co-infection. There is a need for combination therapy and diagnostic approaches to minimize the risks associated with the COVID-19 pandemic effectively.

3.
Infect Disord Drug Targets ; 21(5): e270421186673, 2021.
Article in English | MEDLINE | ID: covidwho-836075

ABSTRACT

The emergence of Severe Acute Respiratory Syndrome (SARS) in named as corona virus disease 19(covid-19) caused by the novel corona virus SARS-CoV-2 has caused hundreds of thousands of mortalities across the world, while the mortality rate is in millions, leading it to be declared as a global pandemic. Numerous research activities are undergoing to reveal the disease and etiological features of covid-19. In this review, some of the interesting aspects of covid-19 are discussed, that include, the origin of the SARS-CoV-2, clinical manifestation, treatment and future aspects of the disease.


Subject(s)
COVID-19 , Humans , Pandemics , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL